Tag archive for ‘RHB-104’

RedHill Biopharma Acquires Technology from University of Minnesota

– The University of Minnesota is buying rights for the development of a diagnostic Crohn’s disease test. Israeli RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) , has entered into a license agreement More...

Jewish Business News On Thursday, June 26th, 2014

Positive Preliminary Pre-Clinical Data for RedHill Biopharma for the Treatment of Type 1 Diabetes

RedHill Biopharma Ltd.(NASDAQ: RDHL; TASE: RDHL) , today announced preliminary positive data from a pre-clinical study with RHB-104 for the treatment of type 1 diabetes, a chronic autoimmune disease with More...

Wordpress site Developed by Fixing WordPress Problems